20/11/2019
As the calendar year comes to a close, The Kids’ Cancer Project proudly announces commitment to an additional six medical research programs to help children with many different types of cancer.

This latest funding announcement represents a significant achievement of the community’s unwavering support as the charity confirms that more than $50 million has been committed to scientific studies since 2004.
 
Childhood cancer remains the deadliest disease for children in Australia, but thanks to the independent national charity and its incredible tribe of donors, partners, fundraisers and advocates that could soon change as Owen Finegan, CEO explains.

“In the past 15 years, The Kids’ Cancer Project has been able to invest $50.53 million in support of bold scientific studies,” says Finegan.

“I’m incredibly proud that over the past five years alone, our commitment has generated more than $35 million in additional research grants seeded by our direct funding,” he says.

His statement was delivered as the organisation finalises the latest round of grant recipients that includes four studies funded in partnership with Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme (full list of successful applicants can be found at https://canceraustralia.gov.au/research-data/research/priority-driven-research).
 
“In total we are proudly supporting 35 medical research programs across 22 research institutions around Australia in the 2019/2020 financial year,” Finegan says.  

Finegan says all the projects combined total more than $10 million in multi-year funding that will support over 47 scientists. Nine of the programs funded are clinical trials to help children with many different types of cancer. 

“In our latest round of grant awards, we’ll be supporting six of the most brilliant researchers and clinicians in our country as they work tirelessly to improve outcomes for all children with cancer,” says Finegan.

Six new studies funded

Enhanced polyamine depletion as a novel therapy for aggressive childhood cancers
Institute: Children’s Cancer Institute
Recipient: Professor Michelle Haber
This study is funded in partnership with the Priority-driven Collaborative Cancer Research Scheme

Application of gene-silencing nanodrugs to inhibit medulloblastoma growth
Institute: Children’s Cancer Institute
Recipient: Associate Professor Joshua McCarroll
This study is funded in partnership with the Priority-driven Collaborative Cancer Research Scheme​

Intraoperative immunotherapy to prevent relapse in soft tissue sarcoma
Institute: Telethon Kids Institute
Recipient: Dr W Joost Lesterhuis
This study is funded in partnership with the Priority-driven Collaborative Cancer Research Scheme​

“Cage fighting" with neuroblastoma
Institute: Macquarie University
Recipient: Dr Andrew Care
This study is funded in partnership with the Priority-driven Collaborative Cancer Research Scheme​

Impact of treatment on late effects and survivorship on childhood cancer survivors
Institute: University of Sydney
Recipient: Professor Natasha Nassar

Reboot-Kids
Institute: 
Sydney Children’s Hospital, Kids Cancer Centre
Recipient: Dr Jennifer Cohen and Professor Claire Wakefield

 
Donate to research and help find more effective treatments for kids with cancer.

 


The Kids' Cancer Project is an ACNC Registered Charity 
ABN 13 061 138 181 | CFN 10581